179 related articles for article (PubMed ID: 12851678)
1. Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase.
Saitoh E; Aoki D; Susumu N; Udagawa Y; Nozawa S
Int J Oncol; 2003 Aug; 23(2):303-10. PubMed ID: 12851678
[TBL] [Abstract][Full Text] [Related]
2. Complementary DNA cloning for galactosyltransferase associated with tumor and determination of antigenic epitopes recognized by specific monoclonal antibodies.
Uejima T; Uemura M; Nozawa S; Narimatsu H
Cancer Res; 1992 Nov; 52(22):6158-63. PubMed ID: 1384956
[TBL] [Abstract][Full Text] [Related]
3. Mouse monoclonal antibodies which recognize a human (beta 1-4)galactosyl-transferase associated with tumor in body fluids.
Uemura M; Sakaguchi T; Uejima T; Nozawa S; Narimatsu H
Cancer Res; 1992 Nov; 52(22):6153-7. PubMed ID: 1423258
[TBL] [Abstract][Full Text] [Related]
4. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis].
Nozawa S; Udagawa Y; Ito K; Nishimura H; Yakushiji M; Shiota M; Noda K; Yajima M; Ohkura H; Murae M
Gan To Kagaku Ryoho; 1994 Mar; 21(4):507-16. PubMed ID: 8129392
[TBL] [Abstract][Full Text] [Related]
6. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (first report)--preclinical study of GAT assay kit and clinical study of normal level].
Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
Gan To Kagaku Ryoho; 1993 Feb; 20(2):271-7. PubMed ID: 8434966
[TBL] [Abstract][Full Text] [Related]
7. Alteration in the metastatic potential of ovarian cancer cells by transfection of the antisense gene of beta-1,4-galactosyltransferase.
Yamashita H; Kubushiro K; Ma J; Fujii T; Tsukazaki K; Iwamori M; Nozawa S
Oncol Rep; 2003; 10(6):1857-62. PubMed ID: 14534708
[TBL] [Abstract][Full Text] [Related]
8. Characterization and immunoassay of human tumor-associated galactosyltransferase isoenzyme II.
Uemura M; Winant RC; Sikic BI; Brandt AE
Cancer Res; 1988 Sep; 48(18):5325-34. PubMed ID: 3136919
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
[TBL] [Abstract][Full Text] [Related]
10. Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient.
Bhattacharya M; Chatterjee SK; Barlow JJ
Cancer Res; 1976 Jun; 36(6):2096-101. PubMed ID: 57828
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma.
Nozawa S; Yajima M; Sakuma T; Udagawa Y; Kiguchi K; Sakayori M; Narisawa S; Iizuka R; Uemura M
Cancer Res; 1990 Feb; 50(3):754-9. PubMed ID: 2105162
[TBL] [Abstract][Full Text] [Related]
12. Correlated gene expression between beta-1,4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines.
Sato T; Shirane K; Kido M; Furukawa K
Biochem Biophys Res Commun; 2000 Oct; 276(3):1019-23. PubMed ID: 11027584
[TBL] [Abstract][Full Text] [Related]
13. [GAT (galactosyltransferase associated with tumor)].
Fukuchi T; Nozawa S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():726-9. PubMed ID: 16149624
[No Abstract] [Full Text] [Related]
14. Murine monoclonal antibodies against galactosyltransferase from the ascites of ovarian cancer patients.
Chatterjee SK; Bhattacharya M; Barlow JJ
Cancer Res; 1984 Dec; 44(12 Pt 1):5725-32. PubMed ID: 6209001
[TBL] [Abstract][Full Text] [Related]
15. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
[TBL] [Abstract][Full Text] [Related]
16. Tumor markers for ovarian cancer.
Bhattacharya M; Barlow JJ
Int Adv Surg Oncol; 1979; 2():155-76. PubMed ID: 95453
[TBL] [Abstract][Full Text] [Related]
17. Enhanced branching morphogenesis in mammary glands of mice lacking cell surface beta1,4-galactosyltransferase.
Steffgen K; Dufraux K; Hathaway H
Dev Biol; 2002 Apr; 244(1):114-33. PubMed ID: 11900463
[TBL] [Abstract][Full Text] [Related]
18. Impaired galactosylation of core 2 O-glycans in erythrocytes of beta1,4-galactosyltransferase knockout mice.
Kotani N; Asano M; Iwakura Y; Takasaki S
Biochem Biophys Res Commun; 1999 Jun; 260(1):94-8. PubMed ID: 10381349
[TBL] [Abstract][Full Text] [Related]
19. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
20. [Galactosyltransferase isozyme II (GT-II) as a new tumor marker for ovarian cancers--especially for clear cell carcinoma].
Nozawa S; Kiguchi K; Yajima M; Udagawa Y; Sakuma T; Iizuka R; Narisawa S; Sakayori M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1341-7. PubMed ID: 2511259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
